Drugmaker Mallinckrodt agreed to a $15.4 million settlement to resolve accusations that Questcor Pharmaceuticals, now owned by Mallinckrodt, provided doctors with meals and entertainment to encourage prescribing of its Acthar gel for multiple sclerosis and other diseases. Authorities said the alleged scheme resulted in the submission of fraudulent claims to Medicare.
Mallinckrodt settles kickback, Medicaid fraud allegations for $15.4M
Sign up for PCMA SmartBrief
Top news for PBMs
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.